AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
(Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and Rinvoq to $27 billion, up $6 billio..
Headlines
All Posts

(Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and Rinvoq to $27 billion, up $6 billio..
Headlines

SUZU, Japan (Reuters) – One month on from a magnitude 7.6 earthquake that struck the west coast of Japan, volunteers from non-pr..
Headlines

Research shows more than one-fifth of male employees in Britain do not consider a peanut allergy to be a serious health condition. The..
Business

NEW YORK/LONDON (Reuters) -Treasury yields jumped, the dollar surged and global equities edged higher on Friday after a blowout U.S. j..
Headlines

NEW YORK (Reuters) – The U.S. dollar index jumped to a seven-week high on Friday after data showed that employers added far mo..
Headlines

(Reuters) – Global equity funds attracted substantial inflows in the week to Jan. 31, driven by upbeat U.S. economic growth data..
Headlines

NEW YORK (Reuters) -Oil prices fell by about 2% on Friday and were headed for weekly losses after U.S. jobs data shrank the odds of im..
Headlines

LONDON (Reuters) -The European Union on Thursday agreed new rules to cut the cost of listing a company and encourage founders to take ..
Headlines

NEW YORK (Reuters) -Oil prices edged higher on Thursday, boosted by the U.S. Federal Reserve signalling a possible start to interest r..
Headlines

LONDON (Reuters) – The Bank of England kept interest rates steady on Thursday, with officials split three ways on the right cour..
Headlines